Vaccine-induced seropositivity/seroreactivity (VISP/R) on common HIV screening assays after vaccination with investigational adenovirus vector-based mosaic HIV regimens in clinical trials.
Saved in:
| Title: | Vaccine-induced seropositivity/seroreactivity (VISP/R) on common HIV screening assays after vaccination with investigational adenovirus vector-based mosaic HIV regimens in clinical trials. |
|---|---|
| Authors: | Callewaert K; Johnson & Johnson, Beerse, Belgium. Electronic address: kcallewa@its.jnj.com., Lavreys L; Johnson & Johnson, Beerse, Belgium. Electronic address: llavrey1@its.jnj.com., Willems W; Johnson & Johnson, Beerse, Belgium. Electronic address: wwillem7@its.jnj.com., van Rosmalen MGM; Johnson & Johnson, Leiden, The Netherlands. Electronic address: mariska.vanrosmalen@gmail.com., Salzgeber Y; Johnson & Johnson, Bern, Switzerland. Electronic address: ysalzgeb@its.jnj.com., Pau MG; Johnson & Johnson, Leiden, The Netherlands. Electronic address: mpau@its.jnj.com., Oriol Mathieu V; Johnson & Johnson, Leiden, The Netherlands. Electronic address: voriolm@its.jnj.com., Hartnett J; Johnson & Johnson, Titusville, USA. Electronic address: jhartne1@its.jnj.com., Vingerhoets J; Johnson & Johnson, Beerse, Belgium. Electronic address: jvingerh@its.jnj.com. |
| Source: | Vaccine [Vaccine] 2026 Apr 19; Vol. 79, pp. 128500. Date of Electronic Publication: 2026 Apr 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41932180 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Vaccine-induced seropositivity/seroreactivity (VISP/R) on common HIV screening assays after vaccination with investigational adenovirus vector-based mosaic HIV regimens in clinical trials. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Callewaert+K%22">Callewaert K</searchLink>; Johnson & Johnson, Beerse, Belgium. Electronic address: kcallewa@its.jnj.com.<br /><searchLink fieldCode="AU" term="%22Lavreys+L%22">Lavreys L</searchLink>; Johnson & Johnson, Beerse, Belgium. Electronic address: llavrey1@its.jnj.com.<br /><searchLink fieldCode="AU" term="%22Willems+W%22">Willems W</searchLink>; Johnson & Johnson, Beerse, Belgium. Electronic address: wwillem7@its.jnj.com.<br /><searchLink fieldCode="AU" term="%22van+Rosmalen+MGM%22">van Rosmalen MGM</searchLink>; Johnson & Johnson, Leiden, The Netherlands. Electronic address: mariska.vanrosmalen@gmail.com.<br /><searchLink fieldCode="AU" term="%22Salzgeber+Y%22">Salzgeber Y</searchLink>; Johnson & Johnson, Bern, Switzerland. Electronic address: ysalzgeb@its.jnj.com.<br /><searchLink fieldCode="AU" term="%22Pau+MG%22">Pau MG</searchLink>; Johnson & Johnson, Leiden, The Netherlands. Electronic address: mpau@its.jnj.com.<br /><searchLink fieldCode="AU" term="%22Oriol+Mathieu+V%22">Oriol Mathieu V</searchLink>; Johnson & Johnson, Leiden, The Netherlands. Electronic address: voriolm@its.jnj.com.<br /><searchLink fieldCode="AU" term="%22Hartnett+J%22">Hartnett J</searchLink>; Johnson & Johnson, Titusville, USA. Electronic address: jhartne1@its.jnj.com.<br /><searchLink fieldCode="AU" term="%22Vingerhoets+J%22">Vingerhoets J</searchLink>; Johnson & Johnson, Beerse, Belgium. Electronic address: jvingerh@its.jnj.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2026 Apr 19; Vol. 79, pp. 128500. <i>Date of Electronic Publication: </i>2026 Apr 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41932180 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.vaccine.2026.128500 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 128500 Titles: – TitleFull: Vaccine-induced seropositivity/seroreactivity (VISP/R) on common HIV screening assays after vaccination with investigational adenovirus vector-based mosaic HIV regimens in clinical trials. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Callewaert K – PersonEntity: Name: NameFull: Lavreys L – PersonEntity: Name: NameFull: Willems W – PersonEntity: Name: NameFull: van Rosmalen MGM – PersonEntity: Name: NameFull: Salzgeber Y – PersonEntity: Name: NameFull: Pau MG – PersonEntity: Name: NameFull: Oriol Mathieu V – PersonEntity: Name: NameFull: Hartnett J – PersonEntity: Name: NameFull: Vingerhoets J IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 04 Text: 2026 Apr 19 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1873-2518 Numbering: – Type: volume Value: 79 Titles: – TitleFull: Vaccine Type: main |
| ResultId | 1 |
